Oncology

Key takeaways

• The intervention was designed around family caregivers' supportive-care needs.
• All four measured need domains favored the smartphone-education group at four weeks.
• The abstract reports statistical significance but does not provide effect sizes or describe the educational content in detail.

Nursing implications

• Assess what caregivers still need to know and use approved digital education as a supplement to individualized teaching and follow-up.

Limitations & cautions

• Abstract-only summary. The trial included 80 caregivers at two hospitals, assessed self-reported needs after only four weeks, and did not report patient outcomes or effect sizes in the abstract.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• Grade 3 or higher infection occurred in 28% versus 41%, respectively.
• Grade 3 or higher hemorrhage occurred in 2% versus 12%, respectively.

Nursing implications

• Reinforce the individualized oncology plan and communicate infection or bleeding concerns promptly.

Limitations & cautions

• Abstract-only summary of an industry-funded phase 2 trial. Core-binding-factor fusions, FLT3 mutations, and NPM1 mutations in patients under 60 were excluded. Event-free survival is not overall survival.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The post hoc analysis included 264 women from a randomized trial of app-based symptom and adherence monitoring.
• Higher baseline symptom-management self-efficacy was associated with lower symptom burden and greater odds of endocrine-therapy adherence.
• The tailored-feedback intervention showed its largest estimated adherence benefit at lower self-efficacy levels.
• The low-self-efficacy estimate had a wide confidence interval, and effects diminished and became nonsignificant at higher self-efficacy levels.

Nursing implications

• Ask how confident the patient feels managing symptoms and the daily regimen, then assess barriers, symptom burden, missed doses, and support preferences. Route concerns through the survivorship or oncology pathway and use remote monitoring only within the approved program.

Limitations & cautions

• This was a post hoc effect-modification analysis rather than a prespecified primary comparison. Adherence was recorded with a connected pillbox, the low-self-efficacy estimate was imprecise, and the findings do not establish that the same intervention will work in other populations or platforms.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The trial randomized 698 patients with active cancer and suspected acute pulmonary embolism.
• A YEARS strategy using clinical items, D-dimer, and risk-dependent CTPA met the prespecified noninferiority criterion.
• The YEARS pathway avoided immediate CTPA in 77 of 352 patients, or 22%.
• The proportion of negative CTPA results did not differ significantly between groups.

Nursing implications

• Recognize and escalate possible PE promptly, collect the clinical information and ordered D-dimer needed for the approved pathway, and verify whether the organization permits YEARS in active cancer. Do not use the trial to independently rule out PE or defer imaging outside protocol.

Limitations & cautions

• The study was open label, applied a prespecified noninferiority margin, and was conducted in 21 European hospitals. The result supports the tested pathway in eligible patients but does not validate unsupervised bedside use or every cancer population.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The open-label single-center trial randomized 60 neutropenic adults entering protective isolation.
• Anxiety decreased more after virtual reality hypnosis than after the control activity.
• Pain ratings were below 2 and did not differ between groups.
• Scorable anxiety data fell from 58 participants on day one to 30 on day three.

Nursing implications

• Assess anxiety, symptoms, device tolerance, and contraindications before use; maintain all protective-isolation precautions during the session; and reassess distress afterward while continuing the broader supportive-care plan.

Limitations & cautions

• The study was open label, single center, and small. The number of participants with scorable anxiety data declined across the three days, pain was minimal at baseline, and the results do not establish durability or generalizability.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The review pooled 19 randomized trials with 1,527 breast cancer surgery patients.
• Postoperative morphine use and pain scores were comparable between the two regional-block techniques.
• Postoperative nausea and vomiting, fentanyl use, rescue analgesia, and analgesia duration were also comparable.
• The findings do not establish that one block is superior for postoperative analgesia.

Nursing implications

• Identify which block the patient received, trend pain at rest and with movement, document rescue analgesia and nausea, and escalate inadequate control or unexpected deterioration through the perioperative team’s pathway.

Limitations & cautions

• The abstract reports pooled comparisons but does not describe heterogeneity, certainty of evidence, or complication rates in detail. Choice of block remains a procedural decision based on patient factors, clinician expertise, and local practice.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• Only 201 of 489 induction-phase participants met response, disease-distribution, and resectability criteria and were randomized.
• Median time to treatment failure was 20.4 months with resection versus 11.8 months with maintenance therapy.
• Grade 3-4 treatment-related adverse events occurred in 39% of assessed surgery-group patients and 21% of maintenance-group patients.
• Two treatment-related deaths occurred in the surgery group; the trial remains ongoing and overall survival was not the reported primary endpoint.

Nursing implications

• Verify the treatment phase and planned timing of therapy around surgery, monitor ordered liver-function, platelet, and urine-protein measures plus the postoperative assessment, and escalate abnormalities through the oncology-surgical pathway. Do not generalize this strategy to patients who did not meet the trial's selection criteria.

Limitations & cautions

• The open-label trial enrolled patients at 24 hospitals in China and randomized only selected responders without extrahepatic metastasis who were considered resectable. Follow-up was 18.4 months, the primary endpoint was time to treatment failure rather than overall survival, and the study was funded in part by the drug manufacturer.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The review included 10 controlled studies of follow-up after an abnormal FIT or fecal occult blood test in health-disparity populations.
• Eight studies evaluated patient navigation, which increased colonoscopy completion versus usual care with a pooled risk ratio of 1.27.
• The navigation result was rated moderate certainty and remained stable across the review's registered pooled analyses.
• Evidence for registry-based quality improvement and low-touch result notification came from one study each.

Nursing implications

• At result communication or transition of care, verify that the patient understands the need for diagnostic colonoscopy, who will arrange it, and how preparation or transportation barriers will be addressed. Track open referrals according to the organization's follow-up process rather than treating an abnormal screening result as a closed task.

Limitations & cautions

• Interventions and follow-up intervals varied, relatively few studies informed each intervention type, and detection data were sparse. The review supports navigation for completion, but it does not identify one universally effective navigation model or establish effects on cancer stage or mortality.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• BRCA1/2 carriers with open family planning began with greater decisional conflict than those who had completed family planning.
• Decision coaching combined an in-person session with a structured, evidence-based aid describing preventive options.
• Among initially undecided participants with open family planning, more reached a preventive decision by 12 weeks with coaching than with usual care.
• The analysis was exploratory and assessed decision process outcomes, not cancer incidence, survival, or the clinical superiority of any option.

Nursing implications

• Clarify what the patient understands about each option, ask how family-planning goals affect timing, and connect unresolved questions to genetics, oncology, gynecology, or fertility specialists through the established pathway. Document preferences and uncertainty without presenting decision completion as consent for a specific intervention.

Limitations & cautions

• This was an exploratory subgroup analysis of a randomized trial, and the abstract does not report subgroup size or long-term clinical outcomes. Reaching a decision does not establish that the decision was durable, preferred later, or medically superior.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The trial randomized 150 consecutive patients to 22-gauge fine-needle biopsy or 19-gauge fine-needle aspiration during EBUS-TBNA.
• Overall diagnostic yield did not differ significantly between the two needle strategies.
• Fine-needle biopsy produced adequate tissue in 98.6% of procedures versus 86.7% with aspiration and yielded larger tissue cores.
• The reported advantage in histologic diagnostic yield came from a post hoc analysis, and minor bleeding was the only reported tolerability issue.

Nursing implications

• For EBUS-TBNA, confirm the planned needle and specimen workflow during the procedural pause, protect labeling and handoff accuracy, and monitor for bleeding in recovery. Present the tissue-adequacy result separately from the unchanged primary diagnostic-yield result when discussing the evidence with the team.

Limitations & cautions

• This was a single-center trial, compared needles of different gauges and designs, and did not show a significant difference in its primary diagnostic-yield outcome. The histologic-yield finding was post hoc, so it cannot establish superiority without confirmation.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The trial randomized 120 patients undergoing transoral endoscopic thyroidectomy via the vestibular approach, with 60 participants per group.
• At day seven, the rehabilitation group had greater cervical mobility in six directions and lower neck pain and disability scores.
• At one month, illness-perception, quality-of-life, and nursing-satisfaction measures favored the rehabilitation group.
• Drainage volume, drain duration, hospital stay, and the incidence of reported postoperative adverse events did not differ between groups.

Nursing implications

• When early exercise is included in the postoperative pathway, verify readiness and movement restrictions, assess baseline pain and neck mobility, teach the prescribed range and frequency, and document tolerance and progress. Stop and escalate airway symptoms, new swelling, bleeding, neurologic symptoms, severe pain, or other postoperative concerns.

Limitations & cautions

• The intervention combined evidence-based rehabilitation nursing with exercises, so the effect of either component cannot be separated. Follow-up was one month, the abstract does not describe blinding, and the findings apply specifically to transoral endoscopic thyroidectomy via the vestibular approach.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The open-label trial randomized 127 children aged 3 to 18 years receiving high-dose methotrexate for acute lymphoblastic leukemia.
• The primary per-protocol analysis included 118 participants with available day-14 outcomes.
• Any-grade and grade II or worse oral mucositis were less frequent with ice-cold saline rinses than with standard oral care alone.
• Mucositis duration did not differ significantly, and no serious oral-cryotherapy-related adverse events were reported.

Nursing implications

• If oral cryotherapy is ordered in the treatment plan, verify timing and technique, assess developmental ability and aspiration risk, monitor tolerance and oral findings, and continue the standard oral-care bundle. Escalate pain, reduced intake, bleeding, ulceration, fever, or suspected infection.

Limitations & cautions

• This was a single-center, open-label trial with a per-protocol primary analysis that excluded nine randomized participants, seven from the cryotherapy group. The subgroup findings were exploratory, and multicenter confirmation with intention-to-treat analysis is needed before routine implementation.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The trial randomized 271 patients after physician-verified suspicion of colorectal cancer, with 222 included as complete cases.
• Self-efficacy increased by an estimated 6.98 points with navigation and 2.06 points with standard care.
• The estimated between-group difference in change was 4.92 points, with a 95% confidence interval from 0.75 to 9.08.
• The intervention combined needs assessment, distress evaluation, and emotional support from diagnosis through treatment completion or follow-up.

Nursing implications

• Use an approved navigation pathway to identify practical and emotional needs, document distress and unresolved barriers, coordinate referrals, and close the loop across treatment transitions. Track patient understanding and confidence rather than assuming that information alone resolves navigation needs.

Limitations & cautions

• Only 222 of 271 randomized participants were included as complete cases, and the abstract reports the self-efficacy outcome without clinical-event, quality-of-life, utilization, or long-term durability results. The intervention was delivered by specially educated navigators, so effects may depend on training and local service design.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The secondary analysis included 518 patients from the multicenter randomized PHYSSURG-C trial.
• The intervention used additional unsupervised moderate physical activity for two weeks before and four weeks after colorectal-cancer surgery.
• The four-week intention-to-treat fatigue difference was 3.75 points, with a 95% confidence interval from 0.01 to 7.49.
• Quality of life, pain, and mental recovery did not differ, and the fatigue analysis was post hoc and exploratory.

Nursing implications

• Assess baseline mobility, fatigue, symptoms, fall risk, nutrition, and barriers to the ordered activity plan. Reinforce the approved progression and stop or escalate for concerning symptoms rather than prescribing an unsupervised exercise dose from this study.

Limitations & cautions

• Fatigue was a post hoc secondary outcome measured with trial-specific self-report questionnaires, the intervention was unsupervised, and the four-week intention-to-treat result was marginal at P=0.05. The study does not establish clinical importance, the best activity dose, or safety and benefit for patients outside the trial's surgical population.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The review included 43 prospective cohorts and phase 2 or later trials in neoadjuvant or adjuvant treatment settings.
• Fatigue was more frequent with immune checkpoint inhibitors than placebo, with a risk ratio of 1.21 and a 95% confidence interval from 1.08 to 1.35.
• Patient-reported outcomes showed a small increase in fatigue, with a standardized mean difference of 0.12.
• The chemotherapy comparison was inconclusive, and study-level bias limits confidence about the magnitude and course of fatigue.

Nursing implications

• Assess fatigue with the approved tool and trend its onset, severity, function, sleep, mood, nutrition, and accompanying symptoms across treatment cycles. Escalate new or worsening fatigue for evaluation of treatment toxicity, endocrine effects, anemia, infection, or other causes according to the oncology pathway.

Limitations & cautions

• The included studies spanned different cancers, agents, treatment settings, and fatigue measures. Risk of bias was high because of allocation concealment and open-label designs, the abstract does not define fatigue severity or trajectory consistently, and the comparison with chemotherapy was imprecise.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The review screened 2,110 records and included 13 clinical guidance documents.
• Thirty-five recommendations were organized into five nursing-process categories.
• The resulting algorithm aims to standardize assessment, planning, intervention, and follow-up.
• The review developed the algorithm but did not test its feasibility, acceptability, or clinical effects.

Nursing implications

• Offer a private, permission-based opportunity to discuss sexual health, assess symptoms and patient priorities, and document concerns using neutral language. Address needs within role and route pain, bleeding, infection concerns, medication effects, pelvic-health needs, or psychosocial distress to the appropriate clinician.

Limitations & cautions

• The review included guidance documents of high and average methodological quality, was not registered, and produced an algorithm without implementation testing. The abstract does not list all 35 recommendations or show that the pathway improves symptoms, quality of life, or care access.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The prospective randomized study assigned 206 adults to a PICC or implantable port and analyzed 192.
• Major complications occurred in 17.8% with PICCs and 4.9% with ports.
• Ports cost more than PICCs when chemotherapy lasted less than six months.
• Overall quality of life did not differ significantly between groups.

Nursing implications

• Verify the selected device and maintenance plan, assess the site and line function before use, and follow the approved dressing, flushing, access, and infection-prevention procedures. Teach patients to report pain, swelling, redness, drainage, fever, resistance, leakage, or device damage promptly.

Limitations & cautions

• The study was conducted at one center, 14 randomized participants were not included in the analysis, and the abstract does not detail individual complication types or blinding. Costs reflect one health system and may not generalize elsewhere.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The phase 3 trial randomized 241 patients with Barcelona Clinic Liver Cancer stage B disease to sequential TACE-ablation or TACE alone.
• Median progression-free survival was 17.7 months with TACE-ablation and 7.3 months with TACE alone.
• Median overall survival was 88.6 months and 35.1 months, respectively.
• Grade 3 or 4 treatment-related adverse events occurred in 23.2% with combination treatment and 18.3% with TACE alone.

Nursing implications

• For patients receiving an approved TACE-ablation sequence, confirm the treatment plan and baseline assessment, complete ordered post-procedure monitoring, and escalate bleeding, severe pain, fever, hemodynamic change, or worsening hepatic symptoms. Reinforce the scheduled imaging, laboratory, and oncology follow-up plan.

Limitations & cautions

• The trial was open label and conducted at two tertiary centers in China; most participants were men. Results apply to the enrolled population with liver-confined, unresectable stage B hepatocellular carcinoma and should not be generalized to other stages, tumor burdens, or ablation approaches.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The review included 37 randomized trials, including four cluster trials, across the breast-cancer care continuum.
• Pooled analyses found higher diagnostic follow-up compliance and screening mammogram adherence with patient navigation.
• Several apparent benefits did not remain statistically significant after a more conservative adjustment.
• Heterogeneity was substantial and the overall methodological quality was low, so the authors called for stronger trials.

Nursing implications

• When navigation is part of your role, document the unresolved care step, responsible team, patient-reported barrier, and next contact date. Use the organization's approved tracking and escalation process for missed screening, abnormal results, delayed diagnostic resolution, or disconnected treatment follow-up.

Limitations & cautions

• Most pooled outcomes had substantial heterogeneity, with I-squared values from 63.9% to 93.0%, and prediction intervals often included no effect. The authors rated overall methodological quality as low, several outcomes could not be pooled, and some benefits disappeared with conservative statistical adjustment.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The trial randomized 202 participants, with 101 assigned to each treatment sequence.
• Pathologic complete response was 55.4% with chemotherapy-first treatment and 42.57% with the conventional sequence.
• Sphincter preservation, resection margins, and surgical complications were similar between groups.
• The survival analysis was exploratory and immature, so the response difference does not establish a long-term survival benefit.

Nursing implications

• Confirm the current phase and sequence at each handoff, reconcile treatment-specific monitoring and supportive-care plans, and promptly communicate hematologic, urinary, gastrointestinal, or other concerning symptoms. Present pathologic response and survival as separate outcomes during education.

Limitations & cautions

• The trial addressed a resource-limited context and enrolled 202 participants. Overall survival was a secondary exploratory outcome and follow-up was not mature; larger studies with longer follow-up are needed before inferring a survival advantage or broad generalizability.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The review included 52 publications addressing precision-oncology nursing roles, competencies, or education.
• Nursing contributions extended from genomic risk assessment and communication to navigation, service integration, and governance.
• Most identified education emphasized foundational capabilities, with less explicit preparation for advanced interpretive and leadership roles.
• The proposed three-level competency model is a framework and has not been validated as an education or patient-outcome intervention.

Nursing implications

• Clarify which genomic conversations, assessments, and coordination tasks fall within the nurse's verified competency and local role. Use approved patient resources, route interpretive questions to qualified genetics or oncology clinicians, and document education and follow-up needs.

Limitations & cautions

• This was a scoping review that mapped a heterogeneous literature and education landscape rather than evaluating effectiveness. The education search included generative-AI-assisted grey-literature methods, identified program availability may change, and the proposed competency levels require validation before they are used for credentialing or scope decisions.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The real-world cohort included 303 patients treated at 18 oncology centers, with 76 patients age 65 or older.
• Response, disease control, treatment modifications, and grade 3 or higher neutropenia were comparable between age groups.
• Chronological age was not independently associated with overall or progression-free survival after adjustment.
• The selected older group and retrospective design limit conclusions about frailer adults or causal treatment effects.

Nursing implications

• Review ordered blood counts and current symptoms before treatment, assess how comorbidities and functional status affect the care plan, and escalate fever, infection concerns, or suspected treatment toxicity promptly. Communicate trends and treatment interruptions so the oncology team can make patient-specific dosing and supportive-care decisions.

Limitations & cautions

• This was a retrospective study of a selected treated population across Central European centers, and only 76 patients were age 65 or older. Age 65 does not capture frailty, selection into treatment may explain apparent similarities, and residual confounding remains. The abstract reports severe neutropenia but does not provide a complete age-stratified adverse-event profile.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The single-center randomized trial enrolled 210 adults aged 65 or older receiving chemotherapy for non-Hodgkin lymphoma.
• Fall incidence among 194 follow-up completers was 7.1% with the preventive nursing program and 19.8% with standard care.
• The intervention group also had better functional-mobility, chemotherapy-completion, and quality-of-life outcomes.
• The 12-week, single-center design and completer analysis limit generalizability.

Nursing implications

• Use the facility's oncology fall-risk process to reassess mobility and treatment-related risks across chemotherapy visits, then individualize prevention measures and document changes. Escalate new weakness, neuropathy, dizziness, falls, or injuries through the oncology team rather than adopting the study protocol without local review.

Limitations & cautions

• The trial was conducted at one center, followed patients for 12 weeks, and reports results for 194 of 210 enrolled participants who completed follow-up. The abstract does not describe allocation concealment, blinding, or every component of the intervention, and the authors call for multicenter, longer-term validation.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The network meta-analysis included 54 randomized trials and 10,455 adults receiving chemotherapy.
• Olanzapine-containing regimens improved multiple nausea and vomiting outcomes versus placebo-containing regimens.
• Direct comparisons did not show significant efficacy differences between 10 mg and 5 mg.
• Dose reduction to 5 mg did not clearly reduce sedation, and evidence for 2.5 mg was very limited.

Nursing implications

• Assess both breakthrough nausea or vomiting and sedation when olanzapine is part of an ordered antiemetic regimen. Do not interpret a lower dose as sedation-free, and communicate symptom-control or tolerability concerns to the oncology team rather than changing prophylaxis independently.

Limitations & cautions

• Network estimates combine direct and indirect comparisons across different chemotherapy regimens, emetogenic-risk groups, and antiemetic backbones. The abstract does not report certainty ratings for each comparison. Evidence for 2.5 mg was sparse, and dose reduction from 10 mg to 5 mg did not clearly reduce sedation.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The trial randomized 51 women newly diagnosed with breast cancer, and 44 completed follow-up.
• The intervention added six weekly Roy-model nursing sessions to standard psycho-oncology care.
• Psychosocial adjustment improved more in the intervention group over time.
• Resilience also improved, with outcomes followed for three months.

Nursing implications

• Oncology services may consider a structured, theory-guided nursing pathway for early adjustment support while preserving standard psycho-oncology care. The study does not establish one universal session format or demonstrate effects on treatment adherence, symptoms, or longer-term outcomes.

Limitations & cautions

• This was a single-center trial with 51 randomized participants and a per-protocol analysis of 44 completers. Outcomes were self-reported, follow-up lasted three months, and the results do not establish effects on cancer treatment, physical symptoms, adherence, or longer-term mental health.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The six-clinic trial randomized 1,214 adults with advanced solid cancer to digital symptom monitoring plus usual care or usual care alone.
• The intervention combined weekly symptom reports, automated self-management guidance, and nurse follow-up for severe alerts.
• Quality of life and self-efficacy were better maintained over 18 weeks with digital monitoring.
• Fewer analyzed participants had worsening unplanned hospitalization episodes, and mean inpatient days were lower, while emergency-department use was not significantly different.

Nursing implications

• For oncology services considering remote monitoring, the intervention should be understood as weekly reporting plus automated guidance plus a staffed nurse-response workflow. The results do not show that passive symptom collection alone is effective, and they should not be generalized beyond the studied advanced-cancer population without local evaluation.

Limitations & cautions

• The trial was conducted in six Hong Kong palliative clinics among community-dwelling adults with advanced solid cancer who were no longer receiving systemic therapy. Follow-up was 18 weeks, caregivers used the app for many participants, and hospitalization and performance-status results in the abstract were reported for smaller analyzed groups than the 1,214 people randomized.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• At 3 to 4 weeks, more intervention patients were free of both diarrhea and constipation than usual-care patients (53.8% vs 27.5%, p=0.01).
• Freedom from constipation alone was also higher in the intervention group (74.4% vs 45%, p=0.01).
• The program was highly feasible (94.1% recruitment, 98.8% completion) and acceptable (over 80% adopted self-management strategies).
• Gains were sustained at 12 weeks within a sub-sample, and the authors call for a fully powered randomized controlled trial.

Nursing implications

• For oncology nurses, the findings suggest that a structured, nurse-led program of dietary education, self-management coaching, and regular telephone follow-up can help chemotherapy patients manage diarrhea and constipation and is well accepted by patients. Because this was a small pilot, any such program should be pursued through the treating team rather than adopted as established practice.

Limitations & cautions

• This was a single-country pilot randomized trial designed to test feasibility rather than to prove effectiveness, so the sample was small and the 12-week outcomes came from a sub-sample of intervention participants only. The culturally tailored, low-resource design may not transfer directly to other settings, and the authors state that a fully powered randomized controlled trial is still needed.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• Honey combined with cryotherapy delayed the onset of radiation-induced oral mucositis (15.58 vs 11.58 days; P = 0.003).
• The incidence of grade II or higher mucositis was lower with the intervention (11.11% vs 33.33%; P = 0.045).
• Severity grading favored the intervention group in both the second week (P = 0.005) and third week (P = 0.014) of treatment.
• The study was small (72 patients, 36 per group) and single-center, and the authors call for further validation.

Nursing implications

• For oncology nurses caring for head and neck cancer patients on chemoradiotherapy, the findings suggest that a structured honey and cryotherapy routine around radiotherapy sessions may postpone and soften oral mucositis, improving comfort and treatment tolerance. Any such protocol should be adopted through the treating team rather than improvised, given the small single-center evidence base.

Limitations & cautions

• This was a single-center prospective study of only 72 patients conducted between July 2021 and May 2022, so the results may not generalize and could reflect local practice. The authors describe the benefit as probable and explicitly call for more comprehensive studies before honey plus cryotherapy is treated as established practice.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• ONS and ASCO jointly published a guideline on managing antineoplastic extravasation, built with GRADE methodology and a systematic review.
• Recommendations address antidote use for vesicants and for irritants with vesicant properties.
• They also address thermal compress application and how long to apply it.
• They call for early surgical referral or specialty escalation for extravasation involving a central venous access device.

Nursing implications

• Know where your unit's extravasation protocol and antidote kit live before a leak happens, and confirm they reflect current ONS/ASCO guidance. Determine whether a leaked agent is a vesicant or an irritant with vesicant properties, apply the correct thermal compress for the recommended duration, and escalate a central venous access device extravasation early rather than waiting.

Limitations & cautions

• As a consensus practice guideline, the strength of individual recommendations depends on evidence that is often limited for a rare event. The abstract names recommendation topics but not specific agents, temperatures, or durations, so the full text must be read before applying any intervention.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The network meta-analysis pooled 49 trials, 24 methods, and 3,887 patients.
• Massage therapy ranked highest for reducing cancer-related fatigue.
• Strengthening exercise ranked lowest in this particular analysis.
• The authors call for larger, higher-quality trials before adopting one approach as best.

Nursing implications

• Assess cancer-related fatigue routinely as a symptom rather than treating it as unavoidable, offer low-risk comfort measures such as massage where appropriate and consistent with the care plan, and avoid presenting any one therapy as proven best given the wide uncertainty.

Limitations & cautions

• Few trials supported each individual therapy, and much of the evidence base used culturally specific modalities, limiting generalizability. The rankings signal promise, not certainty, and do not establish a single recommended program.
• AI-summarized from the linked source. Review the original article before applying to practice.